These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10641793)

  • 1. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts.
    Yu PH; Davis BA
    Int J Biochem Cell Biol; 1999 Dec; 31(12):1391-7. PubMed ID: 10641793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of structural modification of alkyl N-propargylamines on the selective inhibition of monoamine oxidase B activity.
    Yu PH; Davis BA; Boulton AA
    Biochem Pharmacol; 1993 Aug; 46(4):753-7. PubMed ID: 8363648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
    Di Pietro O; Alencar N; Esteban G; Viayna E; Szałaj N; Vázquez J; Juárez-Jiménez J; Sola I; Pérez B; Solé M; Unzeta M; Muñoz-Torrero D; Luque FJ
    Bioorg Med Chem; 2016 Oct; 24(20):4835-4854. PubMed ID: 27396685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.
    Wang J; Edmondson DE
    Biochemistry; 2011 Apr; 50(13):2499-505. PubMed ID: 21341713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
    Sterling J; Herzig Y; Goren T; Finkelstein N; Lerner D; Goldenberg W; Miskolczi I; Molnar S; Rantal F; Tamas T; Toth G; Zagyva A; Zekany A; Finberg J; Lavian G; Gross A; Friedman R; Razin M; Huang W; Krais B; Chorev M; Youdim MB; Weinstock M
    J Med Chem; 2002 Nov; 45(24):5260-79. PubMed ID: 12431053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
    Yu PH; Davis BA; Boulton AA
    Adv Exp Med Biol; 1995; 363():17-23. PubMed ID: 7618520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis.
    Medvedev AE; Veselovsky AV; Shvedov VI; Tikhonova OV; Moskvitina TA; Fedotova OA; Axenova LN; Kamyshanskaya NS; Kirkel AZ; Ivanov AS
    J Chem Inf Comput Sci; 1998; 38(6):1137-44. PubMed ID: 9845968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
    Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
    Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
    Kinemuchi H; Sudo M; Yoshino M; Kawaguchi T; Sunami Y; Kamijo K
    Life Sci; 1983 Jan; 32(5):517-24. PubMed ID: 6823208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
    Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA
    J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors.
    Yu PH; Davis BA; Boulton AA
    J Med Chem; 1992 Oct; 35(20):3705-13. PubMed ID: 1433183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible inhibition of rat liver mitochondrial MAO A and MAO B by enantiomers of deprenyl and alpha-methylpargyline.
    Robinson JB; Bocchinfuso R; Khalil A
    J Pharm Pharmacol; 1995 Apr; 47(4):324-8. PubMed ID: 7791031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.